Johnson & Johnson agreed to pay $33 million to 42 states to settle allegations that its over-the-counter subsidiary falsely claimed have to followed federal manufacturing practices that led to the recall of millions of bottles of Tylenol, Motrin, Benadryl, and Sudafed.
The settlement comes eight years after an embarrassing scandal for the health care giant, which endured congressional investigations, shareholder lawsuits, and a disturbing loss of market share in a key business over its handling of the manufacturing lapses.
About the Author Reprints
